amg63 & hoofa's obj tech thread, page-8

combi i agree with you, we peaked at 6.7cents on 3M speculation alone i don't think that the market nor myself had any idea what 3M were really up to at the time which is why we had such hysteria but in hindsight the SP was far from justified. If the 3M evaluations were favourable then they would have moved onto development. With that in mind a target of 10cents would put our market cap at $115million. With FMCG-1 posting multi-billion dollar sales with their existing formulation i'd expect to see a double digit (lets take 10% royalty rate) i'd say that 115million revenue projection on FMCG-1 alone without P/E ratios is most certainly achieveable. Not only that but the market will then try and take a stab at the other potential revenues from GSK/FMCG-2 and try to factor that in. IMO we should see the SP shoot to an overvaluation stage before the market slowly rests on a comfortable support. How far will the hysteria take us? Well thats too be seen, but i'd say that support at 10cents+ is a very realistic figure.

Sorry Pman, i'm not familiar with the guppy method, sounds like the name for a lolly to me ;) Would love to learn more about that method however.